<DOC>
	<DOCNO>NCT00926185</DOCNO>
	<brief_summary>The purpose study evaluate efficacy three different concentration ( 0.1 % , 1.0 % , 5.0 % ) SAR 1118 Ophthalmic Solution compare placebo treatment dry eye .</brief_summary>
	<brief_title>A Study Evaluating Efficacy SAR 1118 ( 0.1 % , 1.0 % , 5.0 % ) Ophthalmic Solution Subjects With Dry Eye Conducted Controlled Adverse Environment ( CAE )</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Signed Informed Consent Form HIPAA document Willing able comply study procedure Be least 18 year age Patientreported history dry eye eye Demonstrate positive response expose Controlled Adverse Environment model A negative urine pregnancy test female childbearing potential must use adequate birth control throughout study period Any ocular condition , opinion Investigator , could affect study parameter include , limited , active ocular infection , ocular inflammation , glaucoma , and/or diabetic retinopathy Unwilling avoid wear contact lens 7 day prior duration study period Any blood donation significant loss blood within 56 day Visit 1 Any history immunodeficiency disorder , positive HIV , hepatitis B , C , evidence acute active hepatitis A ( antiHAV IgM ) , organ bone marrow transplant . Use topical ophthalmic preparation ( include tear substitute ) 72 hrs prior screen assessment entire study period Any significant illness could interfere study parameter History laserâ€‘assisted situ keratomileusis ( LASIK ) similar type corneal refractive surgery within 12 month prior Visit 1 , and/or ocular surgical procedure within 12 month prior Visit 1 ; schedule ocular surgical procedure study period . Known history alcohol and/or drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Dry Eye</keyword>
	<keyword>ophthalmic delivery</keyword>
</DOC>